Abstract
The aim of this study was to determine the prognostic characteristics of patients with relapsing polychondritis (RP) accompanying cutaneous manifestations in Japan. We analyzed a cohort of 239 patients with RP in view of cutaneous and extracutaneous complications. Thirty three cases (14%) developed cutaneous manifestations and 23 cases had both cutaneous and extracutaneous manifestations. Five RP patients developed myelodysplastic syndrome (MDS) and all of the five patients had cutaneous manifestations, including Sweet’s syndrome. Only one patient died of MDS among the five patients, suggesting rather better prognosis as compared with ordinary MDS. Five RP patients developed Behcet’s disease and all the five patients had cutaneous manifestations. Death rate of the RP patients with cutaneous manifestations (15%) was slightly higher than that of whole Japanese RP patient cohort (9.2%). RP patients with cutaneous manifestations had a slightly higher death rate, than those without cutaneous manifestations. MDS of RP patients had a rather better prognostic impact in Japan. Further studies are needed to elucidate the pathophysiology of RP, which brings about development of extracutaneous manifestations, especially MDS and Behcet’s disease.
Similar content being viewed by others
References
Letko E, Zafirakis P, Baltatzis S, Voudouri A, Livir-Rallatos C, Foster CS (2002) Relapsing polychondritis: a clinical review. Semin Arthritis Rheum 31:384–395
Francès C, el Rassi R, Laporte JL, Rybojad M, Papo T, Piette JC (2001) Dermatologic manifestations of relapsing polychondritis. A study of 200 cases at a single center. Medicine (Baltimore) 80:173–179
Dalamaga M, Karmaniolas K, Matekovits A, Migdalis I, Papadavid E (2008) Cutaneous manifestations in relation to immunologic parameters in a cohort of primary myelodysplastic syndrome patients. J Eur Acad Dermatol Venereol 22:543–548
Oka H, Yamano Y, Shimizu J, Yudoh K, Suzuki N (2014) A large-scale survey of patients with relapsing polychondritis in Japan. Inflamm Regen 34:149–156
Shimizu J, Oka H, Yamano Y, Yudoh K, Suzuki N (2015) Cardiac involvement in relapsing polychondritis in Japan. Rheumatology (Oxford). [Epub ahead of print]
Suzuki N, Shimizu J, Oka H, Yamano Y, Yudoh K (2014) Neurological involvement of relapsing polychondritis in Japan: an epidemiological study. Inflamm Regen 34:206–208
Gergely P Jr, Poór G (2004) Relapsing polychondritis. Best Pract Res Clin Rheumatol 18:723–738
Watkins S, Magill JM Jr, Ramos-Caro FA (2009) Annular eruption preceding relapsing polychondritis: case report and review of the literature. Int J Dermatol 48:356–362. doi:10.1111/j.1365-4632.2009.03935.x
Enright H, Miller W (1997) Autoimmune phenomena in patients with myelodysplastic syndromes. Leuk Lymphoma 24:483–489
Németh-Normand F, Machet L, Vaillant L, Fontes V, Lefrancq T, Lorette G (2002) [Cutaneous vasculitis, myelodysplasia and relapsing polychondritis]. Ann Dermatol Venereol 129:1299-1302. [Article in French]
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
None.
Source of funding
This work and the original epidemiological study [4] were supported in part by Grants-in-Aid from the Research Committee of Rare Disease, the Ministry of Health, Labor and Welfare of Japan.
Rights and permissions
About this article
Cite this article
Shimizu, J., Oka, H., Yamano, Y. et al. Cutaneous manifestations of patients with relapsing polychondritis: an association with extracutaneous complications. Clin Rheumatol 35, 781–783 (2016). https://doi.org/10.1007/s10067-015-3160-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-015-3160-2